Research shows that combining vitamin D and astragalus polysaccharide significantly reduced blood sugar levels and improved insulin resistance in rats with gestational diabetes, according to a 2026 study published in Molecular Biology Reports. Gram Research analysis found the combination decreased blood glucose, reduced liver damage markers, and activated insulin signaling pathways more effectively than either treatment alone. However, this was an animal study, so human trials are needed before recommending it for pregnant people.
Gestational diabetes affects up to 26% of pregnant people and happens when the body can’t use insulin properly. Researchers tested whether combining vitamin D and astragalus (a plant used in traditional medicine) could help fix this problem in rats with pregnancy diabetes. According to Gram Research analysis, the combination significantly lowered blood sugar, improved how the body uses insulin, and reduced harmful inflammation in the liver. While these results are promising, this was an animal study, so scientists need to test whether it works safely in pregnant people before recommending it as a treatment.
Key Statistics
A 2026 animal study found that combining vitamin D and astragalus polysaccharide significantly reduced blood glucose levels and improved insulin resistance markers (HOMA-IR) in rats with gestational diabetes compared to untreated controls (p < 0.05).
According to the 2026 research, the combination treatment decreased harmful liver damage markers (aspartate aminotransferase and alanine aminotransferase) and reduced oxidative stress molecules in liver tissue while increasing protective antioxidant enzymes.
The study demonstrated that vitamin D and astragalus work synergistically, with the combination reducing triglycerides, free fatty acids, and other blood fat markers more effectively than either treatment alone in diabetic rats.
Researchers found that vitamin D receptor and insulin signaling proteins physically interact in liver tissue, suggesting the two treatments work together through complementary molecular mechanisms to improve how cells respond to insulin.
The Quick Take
- What they studied: Whether giving vitamin D and astragalus polysaccharide together could help rats with pregnancy-related diabetes by improving how their bodies use insulin
- Who participated: Laboratory rats (Sprague-Dawley breed) that were made to have gestational diabetes using a high-fat diet and a chemical injection
- Key finding: Rats receiving both vitamin D and astragalus together showed significantly lower blood sugar levels, better insulin function, and less liver damage compared to untreated diabetic rats (p < 0.05)
- What it means for you: This research suggests a potential new treatment approach for pregnancy diabetes, but it’s still in early stages. Pregnant people should not take these supplements without talking to their doctor, as this study was only done in animals
The Research Details
Researchers created rats with gestational diabetes by feeding them a high-fat diet and giving them a chemical that damages the pancreas (similar to how pregnancy diabetes develops in humans). They then divided the diabetic rats into groups: some received vitamin D alone, some received astragalus alone, some received both together, and some received no treatment as a control group. The treatment lasted two weeks.
After treatment, the researchers measured many things in the rats’ blood and liver tissue. They checked blood sugar levels, insulin levels, and fat profiles. In the liver, they looked for signs of damage and stress, measured how well insulin signaling worked, and examined which genes and proteins were turned on or off.
The researchers also used a special technique called co-immunoprecipitation to see if vitamin D and insulin signaling proteins physically interact with each other in liver cells, which would explain how they work together.
This research approach matters because it combines two natural substances that previous studies showed might help separately, but nobody had tested them together before. By looking at the detailed molecular mechanisms in liver tissue, the researchers could explain exactly how and why the combination works better than either treatment alone. This type of detailed investigation helps scientists decide whether a treatment is worth testing in human trials.
This study was published in a peer-reviewed scientific journal, which means other experts reviewed it before publication. However, this is an animal study using rats, not humans, so results may not directly apply to pregnant people. The researchers measured many different markers of health and used proper control groups, which strengthens the findings. The specific statistical significance (p < 0.05) indicates the results are unlikely to be due to chance alone.
What the Results Show
Rats that received both vitamin D and astragalus together showed dramatic improvements compared to untreated diabetic rats. Their blood sugar levels dropped significantly, and their insulin resistance (measured by a standard test called HOMA-IR) improved substantially. The combination also reduced liver damage markers in the blood, including enzymes that leak out when liver cells are injured.
Inside the liver tissue, the researchers found that the combination treatment reduced harmful molecules called reactive oxygen species and malondialdehyde (markers of cellular damage), while increasing protective enzymes like superoxide dismutase. This suggests the treatment reduces oxidative stress, which is a type of cellular damage that contributes to diabetes.
At the molecular level, the combination increased production of vitamin D receptor (VDR) and improved the function of insulin signaling pathways. Specifically, it activated the PI3K/AKT pathway, which is crucial for cells to respond to insulin properly. The treatment also suppressed genes involved in making new glucose (gluconeogenesis) and producing excess fat (lipogenesis), both of which are problems in diabetes.
The co-immunoprecipitation assay revealed that vitamin D receptor and a protein called PI3K p85 physically interact in liver tissue, suggesting they work together as a team to improve insulin sensitivity.
The combination treatment also improved blood fat profiles by reducing triglycerides, free fatty acids, and apolipoprotein B levels, all markers of unhealthy fat metabolism in diabetes. It increased levels of PPARγ, a protein that helps regulate fat and glucose metabolism. The treatment upregulated genes involved in vitamin D metabolism (cytochrome P450 2R1), suggesting the body was better able to process and use vitamin D. Neither treatment alone was as effective as the combination, indicating that vitamin D and astragalus work synergistically (better together than separately).
Previous research showed that vitamin D alone and astragalus alone each help with insulin resistance, but this is the first study examining their combined effects. The findings align with existing knowledge that vitamin D improves insulin signaling through the VDR pathway and that astragalus reduces oxidative stress. This study adds new information by showing these two mechanisms complement each other, vitamin D activates the insulin signaling pathway while astragalus reduces the cellular damage that interferes with that pathway.
This study has several important limitations. First, it was conducted in rats, not humans, so results may not directly translate to pregnant people. Second, the study duration was only two weeks, which is relatively short; we don’t know if benefits continue or if side effects develop with longer use. Third, the sample size of rats in each group was not specified in the abstract, making it harder to assess statistical power. Fourth, this was a laboratory study without examining whether these treatments are safe during pregnancy. Finally, the study doesn’t compare this combination to standard diabetes medications, so we don’t know if it would be better or worse than existing treatments.
The Bottom Line
Based on this animal research, the combination of vitamin D and astragalus polysaccharide shows promise for treating gestational diabetes by improving insulin sensitivity and reducing liver damage. However, confidence in these recommendations is LOW because this is only an animal study. Pregnant people should NOT self-treat with these supplements without medical supervision. The next step is human clinical trials to determine safety and effectiveness in actual pregnancy.
This research is most relevant to: (1) pregnant people with gestational diabetes or at risk for it, (2) researchers studying natural treatments for pregnancy diabetes, and (3) healthcare providers looking for new therapeutic options. This research should NOT be used by pregnant people to self-treat without consulting their obstetrician. People with vitamin D deficiency or those taking blood thinners should be especially cautious, as vitamin D supplements can interact with medications.
In the rat study, improvements appeared within two weeks of treatment. If this translates to humans, benefits might appear within weeks, but this is speculative. Realistic expectations would be several months of consistent use before seeing meaningful improvements in blood sugar control. However, human studies are needed to establish actual timelines.
Frequently Asked Questions
Can pregnant people take vitamin D and astragalus together to treat gestational diabetes?
This combination shows promise in animal studies, but human safety and effectiveness data don’t exist yet. Pregnant people should only consider these supplements under direct medical supervision and after discussing risks with their obstetrician, as pregnancy requires careful medication management.
How does vitamin D help with pregnancy diabetes and insulin resistance?
Vitamin D activates a receptor (VDR) in liver cells that improves insulin signaling pathways, helping cells respond better to insulin. The 2026 study found this mechanism works even better when combined with astragalus, which reduces cellular damage that interferes with insulin function.
What is astragalus polysaccharide and where does it come from?
Astragalus polysaccharide is an active compound extracted from astragalus, a plant used in traditional Chinese medicine for centuries. It appears to reduce oxidative stress (cellular damage) and inflammation, which contribute to insulin resistance in diabetes.
How long does it take to see improvements in blood sugar with this treatment?
In the rat study, improvements appeared within two weeks, but this doesn’t guarantee the same timeline in humans. Realistic expectations would be several weeks to months of consistent use, though actual human data doesn’t exist yet.
Is this treatment better than standard diabetes medications for pregnancy?
The study didn’t compare this combination to standard medications like insulin or metformin. Without direct comparison studies, we can’t determine if it’s better, worse, or equally effective. Pregnant people should follow their doctor’s recommended treatment plan.
Want to Apply This Research?
- Track fasting blood glucose levels weekly and record any changes in energy levels, thirst, or urination frequency. If using the app with medical supervision, log supplement intake dates and times alongside glucose readings to identify patterns.
- If a healthcare provider approves, users could set daily reminders to take vitamin D and astragalus supplements at consistent times, and log their intake in the app. Pair this with tracking dietary choices (especially fat intake) and light physical activity, as the study suggests these supplements work best with lifestyle modifications.
- Establish a baseline of current blood glucose levels and insulin resistance markers (via blood tests ordered by a doctor). Retest these markers every 4-8 weeks if pursuing this treatment under medical guidance. Use the app to track trends over time and share data with healthcare providers to assess whether the combination is working.
This research was conducted in laboratory rats and has not been tested in pregnant humans. Gestational diabetes is a serious medical condition requiring professional medical care. Pregnant people should not start vitamin D supplements, astragalus, or any other supplements without explicit approval from their obstetrician or healthcare provider. These supplements may interact with medications or affect pregnancy. This article is for educational purposes only and should not replace medical advice. Always consult with a qualified healthcare provider before making any changes to pregnancy care or diabetes management.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
